US-based Bio-Techne has launched a new serological assay under its R&D Systems brand for detecting infections caused by the Zika virus.

The sensitive and specific solid phase, enzyme-linked immunosorbent assay (ELISA) will measure anti-Zika virus immunoglobulin G (IgG) antibodies in human serum.

Before performing the new test, samples will be pre-treated with a specific reagent developed to reduce interfering serum proteins that might cause a false positive result.

Upon testing, the R&D Systems Anti-Zika Virus IgG ELISA Kit was found to be highly sensitive to anti-Zika virus IgG and had low cross-reactivity with dengue virus IgG antibodies.

The kit is expected to be beneficial for detection of the infection in samples that were collected five or more days after the onset of symptoms, as well as for samples collected from areas where the disease is known to co-circulate with dengue virus.

“With the recent Zika virus outbreak, we recognise the need for more research dedicated to understanding the biology of emerging viruses.”

Bio-Techne Biotechnology division senior vice-president Dave Eansor said: “With the recent Zika virus outbreak, we recognise the need for more research dedicated to understanding the biology of emerging viruses.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are excited to contribute to this field by focusing on the development of new reagents for detecting viral infections and monitoring anti-viral immune responses.”

The kit can also be used to detect any previous infections and identify if the virus might lead to subsequent neurological disorders or foetal abnormalities.

In addition to the new treatment, Bio-Techne has another Zika virus assay called RNAscope under its Advanced Cell Diagnostics (ACD) brand.

The RNAscope assay is designed to detect low levels of viral RNA in any tissue sample.